Abstract
Pulmonary edema is a life-threatening complication of critical illness. Identification of the underlying mechanisms of pulmonary edema is a prerequisite for the development of adequate treatment. The initial description of fluid transportation across capillaries (Starling’s law) while of critical importance, did not provide full insight into the underlying pathophysiology of vascular leakage. Pulmonary edema can be differentiated into two distinct categories based on the Starling theory; the high-permeability type is attributed to inflammatory changes occurring in conditions such as the adult respiratory distress syndrome (ARDS) and the cardiogenic type is characterized by an imbalance in the Starling hydrostatic forces and occurs in acute or decompensated heart failure. However, it has long been recognized that there is significant overlap between the various types of pulmonary edema, raising important questions regarding the role of novel mechanisms that may contribute to the development of interstitial and alveolar leakage. Recently, several studies on VEGF, an angiogenic growth factor which affects endothelial permeability, have identified this molecule as a potential regulator of vascular leakage and repair in pulmonary edema. We review here the underlying the mechanisms by which VEGF may do this and will discuss the still unanswered questions regarding vascular pharmacology in the setting of pulmonary edema.
Similar content being viewed by others
Abbreviations
- HPPE:
-
High-permeability pulmonary edema
- VEGF:
-
Vascular endothelial growth factor
- CPE:
-
Cardiogenic pulmonary edema
- CHF:
-
Congestive heart failure
- ARDS:
-
Acute respiratory distress syndrome
- ALI:
-
Acute lung injury
- VVO:
-
Vesiculo-vacuolar organelles
- PLC:
-
Phospholipase C
- DAG:
-
Diacylglycerol
- NOS:
-
Nitric oxide synthase
- ELF:
-
Epithelial lining fluid
- BAL:
-
Bronchoalveolar lavage
References
Michel CC, Curry FE (1999) Microvascular permeability. Physiol Rev 79:703–761
Renkin EM (1985) Capillary transport of macromolecules: pores and other endothelial pathways. J Appl Physiol 58:315–325
Reed RK, Berg A, Gjerde EA et al (2001) Control of interstitial fluid pressure: role of beta- integrins. Semin Nephrol 21:222–230
Pietras K, Ostman A, Sjoquist M et al (2001) Inhibition of platelet-derived growth factor receptors reduces interstitial hypertension and increases transcapillary transport in tumors. Cancer Res 61:2929–2934
Murray JF, Nadel JA, Mason RJ et al (2000) Textbook of respiratory medicine. In: Murray JF, Nadel JF (eds) WB Saunders Company, Philadelphia, PA
Braunwald E, Zipes DP, Libby P (2001) Heart disease. In: Brauwald E (ed) Textbook of cardiovascular medicine. WB Saunders Company, Philadelphia, PA
Minnear FL, Barie PS, Malik AB (1985) Effects of large, transient increases in pulmonary vascular pressures on lung fluid balance. J Appl Physiol 55:985
West JB, Mathieu-Costello O (1995) Vulnerability of pulmonary capillaries in heart disease. Circulation 92:622–631
De Pasquale CG, Arnolda LF, Dole IR et al (2003) Prolonged alveolocapillary barrier damage after acute cardiogenic pulmonary edema. Crit Care Med 31(4):1060–1067
Parker JC (2000) Inhibitors of myosin light chain kinase and phosphodiesterase reduce ventilator-induced lung injury. J Appl Physiol 89:2241–2248
Haselton FR, Alexander JS, Mueller SN (1993) Adenosine decreases permeability of in vitro endothelial monolayers. J Appl Physiol 74:1581–1590
Dejana E (1997) Endothelial adherens junctions: implications in the control of vascular permeability and angiogenesis. J Clin Invest 100:S7–S10
Nieuw Amerongen GP, van Delft S, Vermeer MA et al (2000) Activation of RhoA by thrombin in endothelial hyperpermeability: role of Rho kinase and protein tyrosine kinases. Circ Res 87:335–340
Firth JA, Bauman KF, Sibley CP (1987) The intercellular junctions of guinea-pig placental capillaries: a possible structural basis for endothelial solute permeability. J Ultrastruct Res 85:45–57
Kevil CG, Oshima T, Alexander B et al (2000) H2O2-mediated permeability: role of MAPK and occludin. Am J Physiol Cell Physiol 279:C21–C30
Feng D, Nagy JA, Hipp J et al (1996) Vesiculo-vacuolar organelles and the regulation of venular permeability to macromolecules by vascular permeability factor, histamine and serotonin. J Exp Med 183:1981–1986
Ferrara N (2000) VEGF: an update on biological and therapeutic aspects. Curr Opin Biotech 11:617–624
Senger DR, Senger DR, Connolly DT et al (1990) Purification and NH2-terminal amino acid sequence of guinea-pig tumor-secreted vascular permeability factor. Cancer Res 50:1774–1778
Bates DO (1998) The chronic effect of vascular endothelial growth factor on individually perfused frog mesenteric vessels. J Physiol 513:225–233
Wu HM, Huang Q, Yuan Y et al (1996) VEGF induces N-dependent hyperpermeability in coronary venules. Am J Physiol Heart Circulatory Physiol 271:2735–2739
Dvorak AM, et al (1996) The vesiculo-vacuolar organelle (VVO): a distinct endothelial cell structure that provides a transcellular pathway for macromolecular extravasation. J Leukoc Biol 59:100–115
Roberts WG, Palade GE (1995) Increased microvascular permeability and endothelial fenestration induced by vascular endothelial growth factor. J Cell Sci 108:2369–2379
Neal M, Michel CC (1997) Vascular endothelial growth factor (VEGF) induces permeability by inducing openings through endothelial cells. Int J Microcirc Clin Exp 17:198–206
Ferrara N (2002) Role of vascular endothelial growth factor in physiologic and pathologic angiogenesis: therapeutic implications. Semin Oncol 29(6 Suppl 16):10–14
Kaner RJ, Crystal RG (2001) Compartmentalisation of vascular endothelial cell growth factor to the epithelial surface of the human lung. Mol Med 7:240–246
Kaner RJ, Ladetto JV, Singh R et al (2000) Lung overexpression of the vascular endothelial growth factor gene induces pulmonary edema. Am J Resp Cell Mol Biol 22:657–664
Karmpaliotis D, Kosmidou I, Ingenito EP et al (2002) Angiogenic growth factors in the pathophysiology of a murine model of acute lung injury. Am J Physiol Lung Cell Mol Physiol 282(3):585–595
Becker PM, Alcasabas A, Yu AY et al (2000) Oxygen-independent upregulation of vascular endothelial growth factor and vascular barrier dysfunction during ventilated pulmonary ischemia in isolated ferret lungs. Am J Respir Cell Mol Biol 22: 272–279
Gurkan OU, O’Donnell C, Brower R et al (2003) Differential effects of mechanical ventilatory strategy on lung injury and systemic organ inflammation in mice. Am J Physiol Lung Cell Mol Physiol 285(3):L710–L718
Choi WI, Quinn DA, Park KM et al (2003) Systemic microvascular leak in an in vivo rat model of ventilator-induced lung injury. Am J Respir Crit Care Med 167(12):1627–1632
Thickett, Armstrong L, Christie SJ et al (2001) Vascular endothelial growth factor may contribute to increased vascular permeability in acute respiratory distress syndrome. Am J Resp Cell Mol Biol 164(9):1601–1605
Thickett D, Armstrong L, Millar AB (2002) A role for vascular endothelial growth factor in acute and resolving lung injury. Am J Respir Crit Care Med 166:1332–1337
Corne J, Chupp G, Lee CG et al (2000) IL-13 stimulates vascular endothelial cell growth factor and protects against hyperoxic acute lung injury. J Clin Invest 106:783–791
Maitre B, Boussat S, Jean D et al (2001) Vascular endothelial growth factor synthesis in the acute phase of experimental and clinical lung injury. Eur Respir J 18(1):100–116
Gerber HP, Dixit V, Ferrara N (1998) Vascular endothelial growth factor induces expression of the antiapoptotic proteins Bcl-2 and A1 in vascular endothelial cells. J Biol Chem 273:13313–13316
Carpenter T, Schomberg S, Steudel W et al (2003) Endothelin B receptor deficiency predisposes to pulmonary edema formation via increased lung vascular endothelial cell growth factor expression. Circ Res 93(5):456–463
Mann DL (2002) Inflammatory mediators and the failing heart. Past, present and the forsseable future. Circ Res 91:988–998
Milo O, Cotter G, Kaluski E et al (2003) Comparison of inflammatory and neurohormonal activation in cardiogenic pulmonary edema secondary to ischemic versus non-ischemic causes. Am J Cardiol 92:222–226
Matsuno H, Kozawa O, Yoshimi AN et al (2002) Lack of a2-antiplasmin promotes acute heart failure via overrelease of VEGF after acute myocardial infarction. Blood 100(7):2487–2493
Abraham D, Taghavi S, Riml P et al (2002) VEGF-A but not -B mediate increased vascular permeability in preserved lung grafts. Transplanation 73(11):1703–1706
Taghavi S, Abraham D, Riml P et al (2002) Co-expression of endothelin-1 and vascular endothelial growth factor mediates increased vascular permeability in lung grafts before reperfusion. J Heart Lung Transplant 21:600–603
Chin BSP, Chung NAY, Gibbs R et al (2002) Vascular endothelial growth factor and soluble P-selectin in acute and chronic congestive heart failure. Am J Cardiol 90(11):1258–1260
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kosmidou, I., Karmpaliotis, D., Kirtane, A.J. et al. Vascular endothelial growth factors in pulmonary edema: an update. J Thromb Thrombolysis 25, 259–264 (2008). https://doi.org/10.1007/s11239-007-0062-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11239-007-0062-4